Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The muscarinic acetylcholine receptor family comprises five GPCRs mediating diverse cholinergic actions throughout body tissues. Each subtype exhibits unique distribution patterns and signal transduction mechanisms that underpin their varied physiological functions—from cognition and memory formation by central mAChRs like M1/M4/M5 to parasympathetic control over organs by peripheral mAChRs like M2/M3. Advances in structural biology now enable rational design of highly selective ligands aimed at individual muscarinic targets.
Agonism or antagonism of muscarinic acetylcholine receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscarinic Acetylcholine Receptors M1-M5 (mAChRs).